Justera Health Ltd.
SCRSF · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $10 | $437 | $472 | $501 |
| % Growth | -97.7% | -7.4% | -5.8% | – |
| Cost of Goods Sold | $0 | $194 | $151 | $183 |
| Gross Profit | $10 | $243 | $321 | $318 |
| % Margin | 100% | 55.7% | 68.1% | 63.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $400 | $1,904 | $349 | $538 |
| SG&A Expenses | $400 | $1,907 | $353 | $542 |
| Sales & Mktg Exp. | $0 | $3 | $4 | $4 |
| Other Operating Expenses | $26 | $34 | $38 | $38 |
| Operating Expenses | $427 | $1,941 | $391 | $580 |
| Operating Income | -$417 | -$1,698 | -$69 | -$262 |
| % Margin | -4,165.7% | -388.4% | -14.7% | -52.2% |
| Other Income/Exp. Net | $369 | -$1,772 | $39 | $139 |
| Pre-Tax Income | -$48 | -$3,471 | -$31 | -$123 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$509 | -$3,471 | -$31 | -$123 |
| % Margin | -5,093.9% | -793.9% | -6.5% | -24.5% |
| EPS | -0.004 | -0.022 | -0 | -0.001 |
| % Growth | 81.5% | -10,700% | 75% | – |
| EPS Diluted | -0.004 | -0.022 | -0 | -0.001 |
| Weighted Avg Shares Out | 128,309 | 160,806 | 160,806 | 160,806 |
| Weighted Avg Shares Out Dil | 128,309 | 160,806 | 160,806 | 160,806 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $26 | $34 | $38 | $38 |
| EBITDA | -$390 | -$1,664 | -$31 | -$224 |
| % Margin | -3,902.6% | -380.5% | -6.6% | -44.7% |